lasmiditan

CHEBI:CHEBI_747559

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
Lasmiditan hemisuccinate
rxcui
2256947
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
route
ORAL
dosage_form
POWDER
listing_expiration_date
20241231
active_ingredient_strength
1 kg/kg
dea_schedule
CV
marketing_start_date
20201115
package_marketing_start_date
10-DEC-18
labeler_name
Eli Lilly Kinsale Limited
manufacturer_name
Eli Lilly and Company
product_ndc
0002-4491
spl_id
5ef14cf2-d634-4a7b-9254-4cc480e8a48d
active_ingredient_name
LASMIDITAN
package_ndc
0002-4491-62
package_description
1 BLISTER PACK in 1 CARTON (0002-4491-62) / 2 TABLET in 1 BLISTER PACK
brand_name
Reyvow
brand_name_base
Reyvow
application_number
NDA211280
unii
760I9WM792
spl_set_id
aea3358c-ff41-4490-9e6d-c7bf7b3de13f
upc
0300024312081
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class